– USA, CA – Enosi Life Sciences, a drug research and development company focused on providing industry-leading therapeutics for inflammatory autoimmune diseases and cancer, today announced the appointment of antibody therapeutics pioneer, Dr.…
Talent4Boards TeamExecutive Chairman
Cronos Group welcomes Kurt Schmidt as CEO alongside Mike Gorenstein stepping to Executive Chairman role
– CANADA, Toronto – Cronos Group Inc. (TSX: CRON | NASDAQ: CRON) today announced that its Board of Directors has appointed Kurt Schmidt President and CEO effective today, succeeding Mike Gorenstein who has been appointed Executive Chairman.…
C4 Therapeutics appoints Andrew Hirsch as CEO alongside Marc Cohen remaining Executive Chairman
– USA, MA – C4 Therapeutics, a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins through degradation, today announced the hiring of Andrew Hirsch as the incoming CEO.…
4D Molecular Therapeutics (4DMT) appoints Dr John Milligan to its Board of Directors as Executive Chairman
– USA, CA – 4D Molecular Therapeutics, a clinical-stage leader in the development of precision-guided AAV gene therapy based on directed evolution, today announced the appointment of Dr.…
Logiq appoints Tom Furukawa as CEO alongside Brent Suen stepping to Executive Chairman
– USA, MN – Logiq, Inc. (OTC: WEYL), a global provider of eCommerce and fintech business enablement solutions, has promoted global Martech innovator and former CTO of the subsidiary DataLogiq, Tom Furukawa, to the position of CEO, succeeding Brent Suen, who is stepping to the Executive Chairman position and will continue to serve as president.…